Consistent with the in vitro assays, anti–PD-L1 treatment alone activated the antitumor CD8+ T cell response, yet did not significantly induce tumor cell death or inhibit tumor growth (Figure 8, H–J, and Supplemental Figure 8, H–L). The gene discussed is CD8A; the disease is neoplasm.